Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors

Modern Pathology

Volumn 17, Issue 4, 2004, Pages 407-415

  Nikitakis, Nikolaos G ^a,e   Tosios, Konstantinos I ^b   Papanikolaou, Vasileios S ^c   Rivera, Helen ^d   Papanicolaou, Stavros I ^b   Ioffe, Olga B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^e UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Cytokeratins 7 and 20; Immunohistochemistry; Salivary gland tumors; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MIXED TUMOR; MUCOEPIDERMOID TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND TUMOR; ADENOCARCINOMA; ADOLESCENT; CHILD; CLINICAL TRIAL; ENZYME IMMUNOASSAY; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 4644257545     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800064     Document Type: Article

References (33)

1. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
2. Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 1998;31:205-262.
3. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002;38:758-763.
4. Ramaekers F, van Niekerk C, Poels L, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-655.
5. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107.
6. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-972.
7. Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-447.
8. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-388.
9. van de Molengraft FJ, van Niekerk CC, Jap PH, et al. OV-TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancer. Histopathology 1993;22:35-38.
10. Wauters CC, Smedts F, Gerrits LG, et al. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995;26:852-855.
11. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994;102:764-767.
12. Kaufmann O, Deidesheimer T, Muehlenberg M, et al. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology 1996;29:233-240.
13. Chan JK, Suster S, Wenig BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-234.
14. Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999;85:171-177.
15. Tot T. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Cancer 2001;92:2727-2732.
16. Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol Lab Med 2000;124:1196-1200.
17. Bradley PJ. Distant metastases from salivary glands cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:233-242.
18. Seifert G, Hennings K, Caselitz J. Metastatic tumors to the parotid and submandibular glands-analysis and differential diagnosis of 108 cases. Pathol Res Pract 1986;181:684-692.
19. Sobral AP, Loducca SV, Kowalski LP, et al. Immunohistochemical distinction of high-grade mucoepidermoid carcinoma and epidermoid carcinoma of the parotid region. Oral Oncol 2002;38:437-440.
20. Ellis GL, Auclair PL. Tumors of the salivary glands. In: Rosai J, Sobin LH (eds). Atlas of Tumor Pathology, 3rd Series Vol. 17. Armed Forces Institute of Pathology: Washington, DC, 1995.
21. Su L, Morgan PR, Harrison DL, et al. Expression of keratin mRNAs and proteins in normal salivary epithelia and pleomorphic adenomas. J Pathol 1993;171:173-181.
22. Li C, Okamoto Y, Ohmura H, et al. Expression of cytokeratins in Warthin's tumour (adenolymphoma) of parotid glands: specific detection of individual cytokeratin types by monoclonal antibodies. Eur J Cancer B Oral Oncol 1996;32B:352-358.
23. de Araujo VC, de Sousa SO. Expression of different keratins in salivary gland tumours. Eur J Cancer B Oral Oncol 1996;32B:14-18.
24. Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch 2002;440:536-542.
25. Barrett AW, Cort EM, Patel P, et al. An immunohistological study of cytokeratin 20 in human and mammalian oral epithelium. Arch Oral Biol 2000;45:879-887.
26. de Araujo VC, de Sousa SO, Carvalho YR, et al. Application of immunohistochemistry to the diagnosis of salivary gland tumors. Appl Immunohistochem Mol Morphol 2000;8:195-202.
27. Machado de Sousa SO, Soares de Araujo N, Correa L, et al. Immunohistochemical aspects of basal cell adenoma and canalicular adenoma of salivary glands. Oral Oncol 2001;37:365-368.
28. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001;32:596-604.
29. Krogdahl AS, Schou C. Mucinous adenocarcinoma of the sublingual gland. J Oral Pathol Med 1997;26:198-200.
30. Araujo VC, Loducca SV, Sousa SO, et al. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression. Ann Diagn Pathol 2001;5:330-334.
31. de Araujo VC, Kowalski LP, Soares F, et al. Salivary duct carcinoma: cytokeratin 14 as a marker of in situ intraductal growth. Histopathology 2002;41:244-249.
32. Darling MR, Schneider JW, Phillips VM. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol 2002;38:641-645.
33. Regauer S, Beham A, Mannweiler S. CK7 expression in carcinomas of the Waldeyer's ring area. Hum Pathol 2000;31:1096-1101.